2 Micro-Cap Pharma Stocks Worth Watching
In this week’s email to subscribers, independent trader and technical analyst Roberto Pedone commented on a few interesting small- and micro-cap stocks. Below is a look at two micro-cap biopharmaceutical stocks that he likes.
Anthera Pharmaceuticals Inc (NASDAQ: ANTH) is a Delaware-based biopharmaceutical company with a "nice looking ascending triangle chart setup" that looks ready to trigger over $5.10, to $5.25 and then beyond $5.33, Pedone said.
As it can be seen, the stock is "making higher lows over the last three months and now it's bouncing off both its 50-day at $4.54 and its 20-day at $4.69."
The analyst assured he would only play this if gets really robust volume, "since it's tried to break out a few times recently and failed." Support looks solid around $4.60.
Rock Creek Pharmaceuticals
"Chart and share structure gives it a chance, so be on high alert for this one if it gets volume and starts ripping," the analyst said.
"I'm not 100 percent sure if Yahoo Finance has the float right for $RCPI at 7.3 million, but nonetheless the chart is primed. Over $2.03 and then its 20-day at $2.17 could set it off, so look for massive volume like $CBLI had on Tuesday," he added, concluding that this is a thin name, and one should only take it if comfortable trading these.
Image Credit: Public Domain
Latest Ratings for ANTH
|Sep 2015||Citigroup||Initiates Coverage on||Buy|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.